Both live and heat-inactivated LGG supplementation attenuated lung tissue injury caused by <i>M</i>. <i>pneumoniae</i> infection. حسب Huanbing Long (19949784)

الموضوعات:

Dynamic Tracking of <i>In Vivo</i> Receptor Availability in Tumor Using Paired-Agent Imaging حسب Yichen Feng (450964)

الموضوعات:

Dynamic Tracking of <i>In Vivo</i> Receptor Availability in Tumor Using Paired-Agent Imaging حسب Yichen Feng (450964)

الموضوعات:

The pooled effect of COVID-19 infection rate in non-health care workers and health care workers. حسب Zhuoyang Xia (21354186)

الموضوعات:

Graph of the risk of bias for the included randomized controlled trials (A); Summary of the risk of bias for the included randomized controlled trials (B). حسب Zhuoyang Xia (21354186)

الموضوعات:

Cochrane Collaboration’s risk of bias tool. حسب Zhuoyang Xia (21354186)

الموضوعات:

The pooled effect of COVID-19 severe infection rate in non-health care workers and health care workers. حسب Zhuoyang Xia (21354186)

الموضوعات:

Supplementation with LGG effectively influenced the recruitment of innate immune cells following <i>M</i>. <i>pneumoniae</i> infection. حسب Huanbing Long (19949784)

الموضوعات:

The regulation of LGG supplementation of the adaptive immune triggered by <i>M</i>. <i>pneumoniae</i>. حسب Huanbing Long (19949784)

الموضوعات:

The pooled effect of hospitalization rate associated with COVID-19 in non-health care workers and health care workers. حسب Zhuoyang Xia (21354186)

الموضوعات:

Supplementation with LGG modulated the production of cytokines induced by <i>M</i>. <i>pneumoniae</i>. حسب Huanbing Long (19949784)

الموضوعات:

The funnel plot based on COVID-19 infection in non-health care workers (A) and health care workers (B). حسب Zhuoyang Xia (21354186)

الموضوعات:

Scatter plots of the relationships between age and the proportions of cells which statistically significantly correlated with age. حسب Arttu Autio-Kimura (20454681)

الموضوعات:

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Primary and secondary efficacy end points (intention-to-treat population). حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study-related adverse events. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study flow chart. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study CONSORT diagram. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in Demoralization Scale (DSII) by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات: